Meta-research on pragmatism of randomized trials: rationale and design of the PragMeta database

Author:

Hirt Julian1ORCID,Janiaud Perrine1,Düblin Pascal1,Hemkens Lars1ORCID

Affiliation:

1. University of Basel: Universitat Basel

Abstract

Abstract Background Pragmatic trials provide decision-oriented, real-world evidence that is highly applicable and generalizable. The interest in real world evidence is fueled by the assumption that effects in the “real-world” are different to effects obtained under artificial, controlled, research conditions as often used for traditional explanatory trials. However, it is unknown which features of pragmatism, generalizability, and applicability would be responsible for such differences. There is a need to provide empirical evidence and promote meta-research to answer these fundamental questions on the pragmatism of randomized trials and real-world evidence. Here, we describe the rationale and design of the PragMeta database which pursues this goal (www.PragMeta.org). Methods PragMeta is a non-commercial, open data platform and infrastructure to facilitate research on pragmatic trials. It collects and shares data from published randomized trials that either have a specific design feature or other characteristic related to pragmatism or they form clusters of trials addressing the same research question but having different aspects of pragmatism. This lays the foundation to determine the relationship of various features of pragmatism, generalizability, and applicability with intervention effects or other trial characteristics. The database contains trial data actively collected for PragMeta, but also allows to import and link existing datasets of trials collected for other purposes, forming a large-scale meta-database. PragMeta captures data on (1) trial and design characteristics (e.g., sample size, population, intervention/comparison, outcome, longitudinal structure, blinding), (2) effects estimates, and (3) various determinants of pragmatism (e.g., the use of routinely collected data) and ratings from established tools used to determine pragmatism (e.g., the PRragmatic–Explanatory Continuum Indicator Summary 2; PRECIS-2). PragMeta is continuously provided online, inviting the meta-research community to collaborate, contribute, and/or use the database. As of January 25, 2023, PragMeta contains data from >400 trials with assessments on pragmatism. Conclusions PragMeta will inform a better understanding of pragmatism and the generation and interpretation of real-world evidence.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Explanatory and pragmatic attitudes in therapeutical trials;Schwartz D;J Clin Epidemiol,2009

2. GetReal Initiative. GetReal Trial Tool: Navigating RWE options in clinical trials. 2022. https://getrealtrialtool.eu/. Accessed 21 Nov 2022.

3. GetReal Initiative. PragMagic: Pragmatic trial resources. https://www.pragmagic.eu/. Accessed 21 Nov 2022.

4. National Institutes of Health. Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. 2022. https://rethinkingclinicaltrials.org/. Accessed 21 Nov 2022.

5. The PRECIS-2 tool: designing trials that are fit for purpose;Loudon K;BMJ,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3